USANA Health Sciences Inc (USNA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.76 Million) by net assets ($594.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see USANA Health Sciences Inc stock valuation for the company's overall valuation and market capitalisation.
USANA Health Sciences Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
USANA Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of USANA Health Sciences Inc ranked by their cash flow conversion efficiency. Explore USANA Health Sciences Inc earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
i3 Verticals Inc
NASDAQ:IIIV
|
0.036x |
|
TSC Auto ID Technology Co Ltd
TWO:3611
|
0.005x |
|
COG Financial Services Ltd
AU:COG
|
0.198x |
|
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
|
N/A |
|
National Bankshares Inc
NASDAQ:NKSH
|
0.018x |
|
Invesco Municipal Income Opportunities Closed Fund Class Common
NYSE:OIA
|
0.021x |
|
Fiera Capital Corporation
TO:FSZ
|
0.138x |
|
Nuveen Core Plus Impact Fund
NYSE:NPCT
|
N/A |
Annual Cash Flow Conversion Efficiency for USANA Health Sciences Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. View USANA Health Sciences Inc (USNA) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $586.27 Million | $22.35 Million | 0.038x | -63.35% |
| 2024-12-31 | $586.33 Million | $60.99 Million | 0.104x | -26.78% |
| 2023-12-31 | $497.20 Million | $70.64 Million | 0.142x | -40.59% |
| 2022-12-31 | $434.47 Million | $103.90 Million | 0.239x | -22.05% |
| 2021-12-31 | $395.12 Million | $121.23 Million | 0.307x | -15.52% |
| 2020-12-31 | $441.65 Million | $160.40 Million | 0.363x | +0.79% |
| 2019-12-31 | $351.71 Million | $126.73 Million | 0.360x | -7.35% |
| 2018-12-31 | $391.15 Million | $152.12 Million | 0.389x | +14.11% |
| 2017-12-31 | $363.21 Million | $123.78 Million | 0.341x | -19.10% |
| 2016-12-31 | $325.29 Million | $137.03 Million | 0.421x | +6.14% |
| 2015-12-31 | $280.85 Million | $111.47 Million | 0.397x | -13.15% |
| 2014-12-31 | $230.16 Million | $105.19 Million | 0.457x | +20.39% |
| 2013-12-31 | $260.52 Million | $98.89 Million | 0.380x | -24.10% |
| 2012-12-31 | $185.57 Million | $92.81 Million | 0.500x | +24.06% |
| 2011-12-31 | $173.91 Million | $70.11 Million | 0.403x | -11.48% |
| 2010-12-31 | $145.17 Million | $66.11 Million | 0.455x | +4.31% |
| 2009-12-31 | $74.37 Million | $32.47 Million | 0.437x | -69.76% |
| 2008-12-31 | $31.84 Million | $45.96 Million | 1.444x | -2.52% |
| 2007-12-31 | $38.64 Million | $57.22 Million | 1.481x | +47.30% |
| 2006-12-31 | $60.20 Million | $60.52 Million | 1.005x | -4.24% |
| 2005-12-31 | $45.74 Million | $48.02 Million | 1.050x | +31.55% |
| 2004-12-31 | $47.84 Million | $38.18 Million | 0.798x | -0.19% |
| 2003-12-31 | $44.37 Million | $35.48 Million | 0.800x | -9.26% |
| 2002-12-31 | $18.09 Million | $15.94 Million | 0.881x | +28.64% |
| 2001-12-31 | $14.53 Million | $9.95 Million | 0.685x | +116.77% |
| 2000-12-31 | $12.87 Million | $4.07 Million | 0.316x | -72.82% |
| 1999-12-31 | $12.90 Million | $15.00 Million | 1.163x | +235.67% |
| 1998-12-31 | $30.60 Million | $10.60 Million | 0.346x | -5.84% |
| 1997-12-31 | $19.30 Million | $7.10 Million | 0.368x | +8.61% |
| 1996-12-31 | $12.40 Million | $4.20 Million | 0.339x | -42.68% |
| 1995-12-31 | $6.60 Million | $3.90 Million | 0.591x | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more